When comparing prostate cancer patients’ urine exosomes to controls, transcriptome profiling revealed increased levels of PCA-3 (prostate cancer antigen 3 gene) and TMPRSS2-ERG (transmembrane protease serine 2-ETS-related gene). This evidence concerns the gene PCA3 and prostate cancer.